Loading patent…
OwnerBruce M. Spiegelman, Reed Graves +1inventors
InventorsBruce M. Spiegelman, Reed Graves, Susan Ross
Estimating the term…
Regulatory DNA sequences are provided, which are obtained from the 5' flanking region of genes which are expressed primarily in differentiated adipose tissue. These DNA sequences are largely responsible for driving the expression of endogenous genes specifically in adipose tissue in vivo. The DNA sequences can be located in a region 5' of the gene, distinct from promoter sequences which provide a site for the initiation of transcription into DNA, or can be located within the region of the promoter itself. When operatively linked to a gene encoding a recombinant protein capable of exerting an effect on the metabolism of adipocytes, the DNA sequences of the invention can be used to produce transgenic animals which exhibit altered fat tissue metabolism. Depending upon the nature of the gene introduced in the animal or ancestor thereof at an embryonic stage, the transgenic animals are leaner or more obese than non-transgenic animals of the same species.
A DNA sequence comprising an adipose-specific DNA sequence operatively linked through a functional promoter to a heterologous gene coding for a recombinant protein having either a lipolytic or lipogenic effect on adipose tissue, wherein the adipose-specific DNA sequence comprises an enhancer sequence from the 5' flanking region of the gene encoding murine aP2 lipid binding protein, and wherein the enhancer is normally located about 5.4 kb from the site of transcriptional initiation and is capable of directing fat-specific expression of said heterologous gene in vivo.
A murine adipose-specific enhancer element isolated from the 5' flanking region, at about -5.4 kb from the transcription initiation site of transcription of the murine aP2 lipid binding protein gene expressed primarily in differentiated adipocytes, wherein said enhancer element, when operatively linked through a functional promoter to a heterologous DNA sequence coding for a recombinant protein, is capable of directing the expression of the protein specifically in adipose tissue in vivo.
Dependencies are inferred from the claim text.